Market news

Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals The State...

Topics

Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals The State Street SPDR S&P Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF carry identical 0.35% expense ratios. The State Street SPDR S&P Pharmaceuticals ETF has historically exhibited significantly lower price volatility and a smaller maximum drawdown than its biotech counterpart.

QATS is not a registered broker-dealer or investment advisor. All strategies are created and managed by users. Trading involves risk, and past performance is not indicative of future results. QATS does not store or manage user funds. All trades are executed via official broker APIs. Users must be 18 years or older to use the platform.

Maurizio Vitalle 3

© 2026 Quant Algorithm Tree System Ltd.

A better experience starts with cookies

Your data, your choice. We use cookies to improve how things work here.

Cookie policy